Table 2 Psychometric assessment.

From: Glutamatergic dysfunction, neuroplasticity, and redox status in the peripheral blood of patients with motor conversion disorders (functional movement disorders): a first step towards potential biomarkers discovery

 

CTR

FMD

t

df

p

95% CI

BDI-II Total Score, mean ± SD

6.10 ± 6.38

13.42 ± 9.90

−2.55

30

0.016

[−13.17; −1.46]

BAI Total Score, mean ± SD

5.6 ± 4.76

18.42 ± 11.02

−3.819

13.5

0.002

[−20.04; −5.59]

TAS-20—Total Score, mean ± SD

NA

52.33 ± 14.5

NA

NA

NA

NA

TAS-20—alexithymic/not alexithymic

NA

5/7

NA

NA

NA

NA

TAS-20 DIF, mean ± SD

NA

19.42 ± 9.84

NA

NA

NA

NA

TAS-20 DDF, mean ± SD

NA

13.75 ± 4.14

NA

NA

NA

NA

TAS-20 EOT, mean ± SD

NA

19.17 ± 5.83

NA

NA

NA

NA

  1. BAI Beck Anxiety Inventory, BDI-II Beck Depression Inventory, 2nd version, CI confidence interval, CTR healthy controls, df degrees of freedom, FMD functional movement disorders, p p value, SD standard deviation, TAS-20 Toronto Alexithymia Scale—20 items, TAS-20 DDF Difficult Describing Feelings, TAS-20 DIF Difficult Identifying Feelings, t Student’s t.